GTII logo

Green Thumb Industries Stock Price

Symbol: CNSX:GTIIMarket Cap: CA$2.0bCategory: Pharmaceuticals & Biotech

GTII Share Price Performance

GTII Community Fair Values

Recent GTII News & Updates

No updates

Green Thumb Industries Inc. Key Details

US$1.1b

Revenue

US$541.4m

Cost of Revenue

US$599.5m

Gross Profit

US$549.1m

Other Expenses

US$50.3m

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 06, 2025
Earnings per share (EPS)
0.22
Gross Margin
52.54%
Net Profit Margin
4.41%
Debt/Equity Ratio
14.0%

Green Thumb Industries Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About GTII

Founded
2014
Employees
4900
CEO
Benjamin Kovler
WebsiteView website
www.gtigrows.com

Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, capsules, tinctures, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RHYTHM brands. It distributes its products to third-party licensed retail customers; and sells finished products directly to consumers through its retail stores, as well as direct-to-consumer delivery channel. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.

U.S. Market Performance

  • 7 Days: 1.4%
  • 3 Months: 16.3%
  • 1 Year: 17.3%
  • Year to Date: 8.7%
The market is up 1.4% in the last 7 days, led by the Healthcare and all sectors gaining ground. The market is up 17% over the last 12 months. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›
Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
Continue reading